Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
RPRX

Market Cap: $25.98B

RP

Royalty Pharma plc

RPRX

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin89.38%

EBITDA Margin67.66%

EBIT Margin67.47%

Pre-tax Margin53.23%

Net Profit Margin32.15%

Earnings Yield3.13%

Valuation Multiples

Price / Book3.82

Price / Sales10.24

Price / Earnings24.32

PEG7.08

Forward PEG3.32

EV / Sales13.46

EV / EBITDA19.89

EV / Operating Cash Flow11.47

EV / Free Cash Flow11.47

Price / Free Cash Flow8.73

Price / Operating Cash Flow8.76

Cash Flow & Capital

Free Cash Flow / Share$6.69

Operating Cash Flow / Share$6.69

Free Cash Flow Yield11.46%

Capex / Revenue0.00%

Capex / Operating Cash Flow0.00%

Capex / Depreciation0.00

Stock Compensation / Revenue7.83%

Dividend Payout Ratio48.95%

Dividend Yield1.58%

Liquidity & Leverage

Current Ratio1.29

Quick Ratio1.29

Cash Ratio1.29

Debt / Assets0.45

Debt / Capital0.57

Debt / Equity1.31

Long-Term Debt / Capital0.56

Debt / Market Cap34.49%

Net Debt / EBITDA4.75

Solvency Ratio0.08

Financial Leverage2.90

Efficiency & Working Capital

Asset Turnover0.13

Fixed Asset Turnover0.00

Inventory Turnover0.00

Receivables Turnover2.85

Payables Turnover7.57

Days Sales Outstanding128.02

Days Inventory Outstanding0

Days Payables Outstanding48.19

Operating Cycle128.02

Cash Conversion Cycle79.83

Working Capital Turnover4.73

Returns & Quality

Return on Equity12.25%

Return on Assets4.11%

Return on Invested Capital8.96%

ROCE8.24%

Return on Tangible Assets4.31%

Operating Return on Assets7.98%

Income Quality3.72

Tax Burden0.60

Interest Burden0.79

Balance Sheet & Intrinsic Metrics

Enterprise Value$34.13B

Invested Capital$1.1B

Working Capital$181.07M

Tangible Asset Value$8.86B

Net Current Asset Value$-9.22B

Graham Number$25.16

Graham Net-Net-$19.17

Book Value / Share$21.99

Tangible Book Value / Share$19.91

Cash / Share$1.88

Financial Health Scores

Piotroski Score6

Altman Z-Score2.15

Revenue$2.54B

EBIT$1.71B

Market Cap$25.98B

Working Capital$181.07M

Retained Earnings$2.46B

Total Assets$19.82B

Total Liabilities$10.03B